AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20384496
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of 7-valent PCV (PCV7) at ages 2, 4, and 6 months
Trial: 20384496
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of PCV7 at age 12 months
Trial: 12971419
Drug: Protocol A
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol A (three equal, divided doses given with meals over 10 h)
Trial: 12971419
Drug: Protocol B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol B (three equal doses over 14 h)
Trial: 12971419
Drug: Protocol C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol C (four equal doses over 14 h)
Trial: 12971419
Drug: Protocol D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol D (six equal doses over 24 h)
Trial: 10480516
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart (0.2 U/kg)
Trial: 10480516
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (0.2 U/kg)
Trial: 8917741
Drug: ApoCIII genotype
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ApoCIII genotype CC
Trial: 24510496
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g twice daily of creatine monohydrate
Trial: 22237819
Drug: modified Story
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified Story Memory Technique (mSMT) treatment (n = 8)
Trial: 20064185
Drug: MAL PDT
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAL PDT (methyl aminolevulinate) applied as cream 160 mg/g for 3 hours, followed by illumination with broad-spectrum red light (75 J/cm², 570-670 nm), repeated 7 days later.
Trial: 20064185
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied for 3 hours, followed by illumination with broad-spectrum red light (75 J/cm², 570-670 nm), repeated 7 days later.
Trial: 12182270
Drug: Cognitive-Processing Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Processing Therapy (CPT)
Trial: 9696367
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HD-MTX) consolidation and reintensification
Trial: 9696367
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of multidrug induction, HD-MTX consolidation, and reintensification
Trial: 9696367
Drug: Conventional doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional doses of methotrexate
Trial: 9696367
Drug: Short intensive
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short intensive chemotherapy pulses including HD-MTX
Trial: 23265705
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (CRT) and lapatinib followed by lapatinib
Trial: 23265705
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (CRT) and placebo followed by placebo
Trial: 17084249
Drug: Torcetrapib 90
RxNorm normalized name: Torcetrapib
DrugBank: Torcetrapib (DB06281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torcetrapib 90 mg/day
Trial: 17084249
Drug: Torcetrapib 60
RxNorm normalized name: Torcetrapib
DrugBank: Torcetrapib (DB06281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torcetrapib 60 mg/day
Trial: 9280206
Drug: Dietary salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary salt restriction with a low-salt diet (20 mmol sodium chloride per day) and a supplement of 20 tablets of slow sodium (10 mmol NaCl per tablet) for 7 days
Trial: 8301803
Drug: TPN during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPN during chemotherapy
Trial: 23489113
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of terlipressin (4 mg/24 h)
Trial: 23489113
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of terlipressin (2 mg) followed by intermittent injections (1 mg/6 h)
Trial: 15046380
Drug: Meloxicam (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam (7.5 mg)
Trial: 15046380
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three drugs (nimesulide, meloxicam, rofecoxib)
Trial: 9836480
Drug: Cisplatin (single-agent,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (single-agent, higher dose)
Trial: 8157946
Drug: Captopril (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (average dose 72 mg/day for 24 weeks)
Trial: 15123028
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam 0.2 mg/kg
Trial: 28893496
Drug: Moist hot
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moist hot pack (MHP) for 15 minutes during therapy
Trial: 28893496
Drug: Therapeutic whirlpool
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic whirlpool bath (WB) for 15 minutes during therapy
Trial: 25106447
Drug: Co-careldopa treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-careldopa treatment in addition to routine NHS occupational and physical therapy
Trial: 25106447
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment in addition to routine NHS occupational and physical therapy
Trial: 17595175
Drug: Immediate incentives
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate incentives ($5 weekly)
Trial: 27454263
Drug: Ibuprofen 50
RxNorm normalized name: ibuprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 50 mg
Trial: 3547351
Drug: Ibuprofen 100
RxNorm normalized name: ibuprofen 100 MG
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 100 mg
Trial: 9602959
Drug: Rescue medication
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue medication (Acetaminophen 500 mg)
Trial: 8027413
Drug: Bupropion (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (225 to 450 mg/day)
Trial: 8027413
Drug: Trazodone (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone (150 to 400 mg/day)
Trial: 4851085
Drug: MOPP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP treatment plus bleomycin
Trial: 4851085
Drug: MOPP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP treatment
Trial: 4851085
Drug: MOPP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP treatment (maintained group for 24 months)
Trial: 28177725
Drug: Phosphatidic acid
RxNorm normalized name: LYSOPHOSPHATIDIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidic acid (PA) supplementation (750 mg)
Trial: 9535996
Drug: LAAM 20
RxNorm normalized name: LAAM
DrugBank: Levacetylmethadol (DB01227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAAM 20 mg/70 kg i.v.
Trial: 9535996
Drug: LAAM 40
RxNorm normalized name: LAAM
DrugBank: Levacetylmethadol (DB01227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAAM 40 mg/70 kg i.v.
Trial: 9535996
Drug: LAAM 20
RxNorm normalized name: LAAM
DrugBank: Levacetylmethadol (DB01227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAAM 20 mg/70 kg p.o.
Trial: 9535996
Drug: LAAM 40
RxNorm normalized name: LAAM
DrugBank: Levacetylmethadol (DB01227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAAM 40 mg/70 kg p.o.
Trial: 8070500
Drug: U-62066E with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-62066E with high dose naloxone
Trial: 8070500
Drug: U-62066E with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-62066E with low dose naloxone
Trial: 2653893
Drug: gemeprost 1
RxNorm normalized name: Gemeprost 1 mg vaginal pessary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemeprost 1 mg vaginal pessaries at 3 hours intervals up to a maximum of 5 mg
Trial: 2653893
Drug: PGF2 alpha
RxNorm normalized name: Prostaglandin PGF2 alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGF2 alpha 40 mg intra-amniotic dose
Trial: 1091343
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (sustained-release capsule and regular tablet)
Trial: 28099485
Drug: Unadjuvanted H5N1
RxNorm normalized name: influenza, H5N1-1203
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unadjuvanted H5N1 vaccine
Trial: 29911772
Drug: 5% minoxidil
RxNorm normalized name: MINOXIDIL 5 g in 100 mL TOPICAL LIQUID [ASDTOTIO 5% minoxidil]
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5% minoxidil milky lotion
Trial: 20852438
Drug: Brimonidine bid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brimonidine bid (twice daily)
Trial: 20852438
Drug: Brimonidine tid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brimonidine tid (three times daily)
Trial: 10418209
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER (5-10 mg once daily, doubled if necessary)
Trial: 10418209
Drug: Diltiazem SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem SR (90-180 mg once daily, doubled if necessary)
Trial: 7592246
Drug: Diskus inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diskus inhaler (salmeterol 50 micrograms twice daily)
Trial: 7592246
Drug: Diskhaler inhaler
RxNorm normalized name: zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Diskhaler inhaler (salmeterol 50 micrograms twice daily)
Trial: 2087855
Drug: Nisoldipine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 0.3 mg
Trial: 15528910
Drug: Sugar-free gum
RxNorm normalized name: Diabetic Multivitamin Sugar-Free Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-free gum containing 18.8 mg of CPP-ACP
Trial: 9488234
Drug: Lacidipine 4
RxNorm normalized name: lacidipine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 4 mg per day
Trial: 8162007
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (1 g/d for 2 weeks followed by 1.5 g/d)
Trial: 8162007
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (0.5 g/d for 1 month, 0.750 g/d during the second month, then 1 g/d)
Trial: 3096633
Drug: 50 mcg
RxNorm normalized name: D3, 50 mcg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mcg ethinyl estradiol and 1.0 mg ethynodiol diacetate (EED)
Trial: 3096633
Drug: 50 mcg
RxNorm normalized name: D3, 50 mcg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mcg ethinyl estradiol and 1.0 mg norethindrone acetate (ENA)
Trial: 3096633
Drug: 50 mcg
RxNorm normalized name: D3, 50 mcg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mcg ethinyl estradiol and 0.5 mg d‐1 norgestrel (ENG)
Trial: 21919543
Drug: Atorvastatin/metformin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin/metformin ER 10mg/500mg FDC
Trial: 21919543
Drug: Atorvastatin 10mg
RxNorm normalized name: AMLODIPINE 5MG/ATORVASTATIN 10MG TAB
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10mg (Lipitor®) and metformin 500mg (Glucophage® XR)
Trial: 19883295
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate (OTU) 80 mg twice daily
Trial: 19883295
Drug: DHEA 50
RxNorm normalized name: Natrol Mood & Stress DHEA 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 50 mg twice daily
Trial: 17016711
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg)
Trial: 12764904
Drug: TCM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCM plus western medicine
Trial: 11734672
Drug: bezafibrate therapy
RxNorm normalized name: bezafibrate
DrugBank: Bezafibrate (DB01393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bezafibrate therapy (400 mg/day for 6 weeks)
Trial: 8060578
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 to 40 mg twice daily)
Trial: 8060578
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 to 50 mg twice daily)
Trial: 3051879
Drug: Tamoxifen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (10 mg daily)
Trial: 30455336
Drug: Insulin correction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin correction factor adjusted by 50%
Trial: 30455336
Drug: Insulin correction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin correction factor adjusted by 100%
Trial: 30455336
Drug: Insulin correction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin correction factor adjusted by 150%
Trial: 30455336
Drug: Insulin correction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin correction factor adjusted by 0%
Trial: 24917940
Drug: Prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 2 mg once daily
Trial: 19911858
Drug: Prucalopride (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride (2 mg and 4 mg)
Trial: 17064648
Drug: Allergoid SLIT
RxNorm normalized name: Coccidioides immitis spherule
DrugBank: Coccidioides immitis spherule (DB11294)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergoid SLIT for grass pollens (active treatment)
Trial: 15193479
Drug: Clomiphene citrate,
RxNorm normalized name: ClomiPHENE Citrate, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate, high‐dose recombinant human FSH, and a delayed, multidose GnRH antagonist
Trial: 10895837
Drug: Euglycemia (5.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euglycemia (5.01 +/‐ 0.02 mmol/l) maintained for 225 +/‐ 3 min
Trial: 10895837
Drug: Hypoglycemic condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemic condition (plasma glucose at 2.65 +/‐ 0.02 mmol/l for 90 min)
Trial: 8873690
Drug: Bumetanide (0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide (0.005 to 0.10 mg/kg, single intravenous dose)
Trial: 24450390
Drug: T2D treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T2D treatment
Trial: 19446968
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (placebo patch)
Trial: 17046476
Drug: Continuous nebulized
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous nebulized albuterol (15 mg) alone (A)
Trial: 17046476
Drug: Continuous nebulized
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) (AI)
Trial: 11095346
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b at a dose of 5 million units (MU) daily
Trial: 11095346
Drug: Standard interferon
RxNorm normalized name: INTERFERON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard interferon at a dose of 3 MU three times a week (t.i.w.)
Trial: 11095346
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b at a dose of 5 MU daily
Trial: 6146499
Drug: Nadolol (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (once daily)
Trial: 6148868
Drug: Nadolol plus
RxNorm normalized name: Nadolol
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nadolol plus bendroflumethiazide (both once daily)
Trial: 6359851
Drug: Hydralazine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (25 to 100 mg twice daily)
Trial: 31970931
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (topical prednisolone and cycloplegic drops with orbital floor injection of Triamcinolone acetonide)
Trial: 25037665
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) for TMD
Trial: 20522533
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment (0.33 mg/kg per week)
Trial: 15643481
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate (SH) injection
Trial: 16091920
Drug: Triamsinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamsinolone acetonide injection
Trial: 30717815
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) for antenatal depression
Trial: 25034330
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Cistiquer
Trial: 25034330
Drug: Intra-vesical administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-vesical administration of betametasone 8 mg plus gentamicin 80 mg
Trial: 21505910
Drug: Low-dose XLGB
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose XLGB (3 g/day, n=61)
Trial: 21505910
Drug: High-dose XLGB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose XLGB (6 g/day, n=58)
Trial: 18625763
Drug: Raltegravir at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir at 400 mg twice daily for 4 days
Trial: 18625763
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate (TDF) at 300 mg once daily for 7 days
Trial: 18625763
Drug: Raltegravir at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir at 400 mg twice daily plus TDF at 300 mg once daily for 4 days
Trial: 11323536
Drug: TRT-100 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRT-100 (100 mg oral ketoprofen)
Trial: 11323536
Drug: TRT-25 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRT-25 (25 mg oral ketoprofen)
Trial: 7909525
Drug: Optimal intracellular
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal intracellular glutathione levels (20-30 nmol/mg protein)
Trial: 7909525
Drug: Suboptimal intracellular
RxNorm normalized name: ACTIVIN RECEPTOR TYPE IIA (SYNTHETIC HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN HEAVY CHAIN FC FRAGMENT), DIMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suboptimal intracellular glutathione levels (10-20 nmol/mg protein)
Trial: 3209275
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg, verapamil 80 mg, diltiazem 60 mg three times a day (calcium antagonists)
Trial: 3209275
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (Nifedipine, Verapamil, Diltiazem)
Trial: 27984524
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (exercise + CBT)
Trial: 21410107
Drug: AVI with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVI with postoperative subconjunctival bevacizumab (SCB) injections (days 1 and 7)
Trial: 11673930
Drug: Specific manipulative
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific manipulative therapy treatment
Trial: 3339790
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of folate plus 500 micrograms of hydroxocobalamin
Trial: 28914087
Drug: Myofascial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myofascial therapy (12 sessions)
Trial: 28914087
Drug: Standard physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physical therapy program + Myofascial therapy